Navigation Links
CPF Appoints Mishka Michon Chief Executive Officer
Date:1/29/2008

SAN JOSE, Calif., Jan. 29 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) announced the appointment of Mishka Michon as its new Chief Executive Officer. Michon has more than 25 years of experience overseeing all aspects of development, a key area of importance in leadership for non-profit foundations such as the CPF. Michon will lead the CPF's next phase of growth, including expanding CPF fundraising capabilities and driving its overall mission to accelerate research efforts into the deadly, incurable lung disease.

"Mishka brings a wealth of proven experience and success in the non-profit fundraising community into her new role as CEO," said Marvin Schwarz, MD, Chairman of the CPF Board of Directors. "Mishka's leadership will be critical to the long term growth and success of the CPF and her vision will help the foundation expand its role as a major source of research funding in the fight against Idiopathic Pulmonary Fibrosis (IPF)."

Michon joined the CPF in June 2006 as Executive Vice President of Development. Her work helped increase the foundation's charitable contributions and staffing and she led its efforts to increase visibility amongst corporate and individual donors.

"I am committed to the success of the CPF and to helping take the Foundation to its next phase of growth and beyond," said Michon. "I have seen firsthand the people who have been touched by IPF and realize the great need and opportunity that exists for helping to find treatments and a cure for this devastating disease."

Michon replaces Mark Shreve who will be assuming the role as Chief Operating Officer of the foundation. Shreve made the decision in recent weeks to revise his role with the foundation due to family obligations and professional demands of the job. Shreve will remain an integral part of the day to day operations of the CPF.

Before joining the CPF, Michon served as a consultant to non-profit organizations in building development programs and events in Southern California. She was director of development for the west coast division of the Museum of Television and Radio and the director of major gifts for the Shoah Visual History Foundation. She has been affiliated with top tier universities, including UCLA and USC, where she served as a director of major gifts. Along with directing the development for one of the campus colleges, she was interim director of corporate and foundation relations for California State University, Northridge. Her experience also includes positions as development director for the ERAS Center for Children with Learning Disabilities and the John Tracy Clinic. Michon received her Bachelor of Arts degree from UCLA.

About the Coalition for Pulmonary Fibrosis

The Coalition for Pulmonary Fibrosis (CPF) is a 501(c)(3) nonprofit organization, founded in 2001 to accelerate research efforts leading to a cure for idiopathic pulmonary fibrosis (IPF), while educating, supporting, and advocating for the community of patients, families, and medical professionals fighting this disease. The CPF funds promising research into new approaches to treat and cure pulmonary fibrosis; provides patients and families with comprehensive education materials, resources, and hope; serves as a voice for national advocacy of IPF issues; and works to improve awareness of IPF in the medical community as well as the general public. The CPF's nonprofit partners include many of the most respected medical centers and healthcare organizations in the U.S. With more than 14,000 members nationwide, the CPF is the largest nonprofit organization in the U.S. dedicated to advocating for those with pulmonary fibrosis. For more information please visit http://www.coalitionforpf.org or call (888) 222-8541.


'/>"/>
SOURCE Coalition for Pulmonary Fibrosis
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. QualityMetric Appoints Chief Innovation and Research Officer
2. Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing
3. Murad, Inc. Appoints Jeff Murad to Vice-President of Product Development
4. ZYTO Corp. Appoints New Chief Operations Officer and New Chief Financial Officer
5. Batesville Holdings, Inc., Appoints Cynthia L. Lucchese Senior Vice President and Chief Financial Officer
6. VNUS Medical Technologies Appoints Peter Osborne as Chief Financial Officer
7. LifeSync Corporation Appoints Nancy McLane as Senior Vice President Operations
8. ChemoCentryx Appoints Edward E. Penhoet, Ph.D., to Board of Directors
9. Cardiva Medical, Inc. Appoints Two New Officers: Malcolm Farnsworth as Vice President of Finance and Chief Financial Officer and Tara Zerby as Vice President of Business Development and Marketing
10. Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion
11. LifeVantage Corporation Appoints Industry Veteran David Brown as President & CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: